C2C12 myoblast differentiation stimulated by octacalcium phosphate material
Source abstract
Abstract
To know about whether a bone substitute material octacalcium phosphate (OCP) is associated with bone formation by acting on surrounding tissue-derived cells, such as muscle cells, the effect of OCP was investigated on muscle-derived myoblast C2C12 cells in vitro. C2C12 cells were cultured with or without OCP granules. The diameter of the myotube formed from C2C12 cells with OCP was larger than that without OCP. mRNA expressions of myoblast differentiation markers (MyHC, MCK) and myokine (FGF-2) were increased by OCP, while Fndc5 and osteoglycin (myokine) were decreased. The alkaline phosphatase activity of mesenchymal stem cells was increased by adding the extract of media cultured with C2C12 cells and OCP up to 14 days. The chemical and spectroscopic analyses indicated that OCP hydrolysis progressed towards Ca-deficient hydroxyapatite in the media. The results suggest that OCP promotes myoblast differentiation and assists osteoblast differentiation through the myokines secretion under the environment induced by OCP hydrolysis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone health and osteoporosis research · Bone health and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Craniofacial Function Engineering (Division of Biomaterials Science and Engineering), Tohoku University Graduate School of Dentistry
Division of Oral and Maxillofacial Reconstructive Surgery, Tohoku University Graduate School of Dentistry
References (69)
Show source-provided references
1. 1) Brown WE. Crystal growth of bone mineral. Clin Orthop Relat Res 1966; 44: 205-220.10.1097/00003086-196600440-00021 ↗
2. 2) Simon P, Grüner D, Worch H, Pompe W, Lichte H, El Khassawna T, et al. First evidence of octacalcium phosphate@ osteocalcin nanocomplex as skeletal bone component directing collagen triple-helix nanofibril mineralization. Sci Rep 2018; 8: 13696.10.1038/s41598-018-31983-5 ↗
3. 3) Tseng YH, Mou CY, Chan JC. Solid-state nmr study of the transformation of octacalcium phosphate to hydroxyapatite: A mechanistic model for central dark line formation. J Am Chem Soc 2006; 128: 6909-6918.10.1021/ja060336u ↗
4. 4) Suzuki O, Nakamura M, Miyasaka Y, Kagayama M, Sakurai M. Bone formation on synthetic precursors of hydroxyapatite. Tohoku J Exp Med 1991; 164: 37-50.10.1620/tjem.164.37 ↗
5. 5) Suzuki O, Kamakura S, Katagiri T, Nakamura M, Zhao B, Honda Y, et al. Bone formation enhanced by implanted octacalcium phosphate involving conversion into ca-deficient hydroxyapatite. Biomaterials 2006; 27: 2671-2681.10.1016/j.biomaterials.2005.12.004 ↗
6. 6) Imaizumi H, Sakurai M, Kashimoto O, Kikawa T, Suzuki O. Comparative study on osteoconductivity by synthetic octacalcium phosphate and sintered hydroxyapatite in rabbit bone marrow. Calcif Tissue Int 2006; 78: 45-54.10.1007/s00223-005-0170-0 ↗
7. 7) Miyatake N, Kishimoto KN, Anada T, Imaizumi H, Itoi E, Suzuki O. Effect of partial hydrolysis of octacalcium phosphate on its osteoconductive characteristics. Biomaterials 2009; 30: 1005-1014.10.1016/j.biomaterials.2008.10.058 ↗
8. 8) Kawai T, Kamakura S, Matsui K, Fukuda M, Takano H, Iino M, et al. Clinical study of octacalcium phosphate and collagen composite in oral and maxillofacial surgery. J Tissue Eng 2020; 11: 2041731419896449.10.1177/2041731419896449 ↗
9. 9) Saito K, Anada T, Shiwaku Y, Chiba S, Miyatake N, Suzuki K, et al. Dose-dependent enhancement of octacalcium phosphate biodegradation with a gelatin matrix during bone regeneration in a rabbit tibial defect model. RSC Advances 2016; 6: 64165-64174.10.1039/C6RA07602E ↗
10. 10) Hamada S, Mori Y, Shiwaku Y, Hamai R, Tsuchiya K, Baba K, et al. Octacalcium phosphate/gelatin composite (OCP/Gel) enhances bone repair in a critical-sized transcortical femoral defect rat model. Clin Orthop Relat Res 2022; 480: 2043-2055.10.1097/CORR.0000000000002257 ↗
11. 11) Brown WE, Smith JP, Lehr JR, Frazier AW. Octacalcium phosphate and hydroxyapatite: Crystallographic and chemical relations between octacalcium phosphate and hydroxyapatite. Nature 1962; 196: 1050-1055.10.1038/1961050a0 ↗
12. 12) Mathew M, Brown WE, Schroeder LW, Dickens B. Crystal structure of octacalcium bis(hydrogenphosphate) tetrakis(phosphate)pentahydrate, Ca8(HPO4)2(PO4)4•5H2O. J Crystallogr Spectrosc Res 1988; 18: 235-250.10.1007/BF01194315 ↗
13. 13) Brown WE, Mathew M, Tung MS. Crystal chemistry of octacalcium phosphate. Prog Cryst Growth Charact 1981; 4: 59-87.10.1016/0146-3535(81)90048-4 ↗
14. 14) Chow LC. Next generation calcium phosphate-based biomaterials. Dent Mater J 2009; 28: 1-10.10.4012/dmj.28.1 ↗
15. 15) Driessens FC. Physiology of hard tissues in comparison with the solubility of synthetic calcium phosphates. Ann N Y Acad Sci 1988; 523: 131-136.10.1111/j.1749-6632.1988.tb38507.x ↗
16. 16) Meyer JL, Eanes ED. A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation. Calcif Tissue Res 1978; 25: 59-68.10.1007/BF02010752 ↗
17. 17) Meyer JL, Eanes ED. A thermodynamic analysis of the secondary transition in the spontaneous precipitation of calcium phosphate. Calcif Tissue Res 1978; 25: 209-216.10.1007/BF02010771 ↗
18. 18) Suzuki O. Adsorption of bovine serum albumin onto octacalcium phosphate and its hydrolyzates. Cell Mater 1995; 5: 45-54.
19. 19) Suzuki O, Yagishita H, Amano T, Aoba T. Reversible structural changes of octacalcium phosphate and labile acid phosphate. J Dent Res 1995; 74: 1764-1769.10.1177/00220345950740110801 ↗
20. 20) Chickerur NS, Tung MS, Brown WE. A mechanism for incorporation of carbonate into apatite. Calcif Tissue Int 1980; 32: 55-62.10.1007/BF02408521 ↗
21. 21) Suzuki O, Kamakura S, Katagiri T. Surface chemistry and biological responses to synthetic octacalcium phosphate. J Biomed Mater Res B Appl Biomater 2006; 77: 201-212.10.1002/jbm.b.30407 ↗
22. 22) Suzuki O, Nakamura M, Miyasaka Y, Kagayama M, Sakurai M. Maclura pomifera agglutinin-binding glycoconjugates on converted apatite from synthetic octacalcium phosphate implanted into subperiosteal region of mouse calvaria. Bone Miner 1993; 20: 151-166.10.1016/S0169-6009(08)80024-4 ↗
23. 23) Kaneko H, Kamiie J, Kawakami H, Anada T, Honda Y, Shiraishi N, et al. Proteome analysis of rat serum proteins adsorbed onto synthetic octacalcium phosphate crystals. Anal Biochem 2011; 418: 276-285.10.1016/j.ab.2011.07.022 ↗
24. 24) Kodama T, Goto T, Ishibe T, Kobayashi S, Takahashi T. Apolipoprotein E stimulates bone formation on titanium in vitro. Asian J Oral Maxillofac Surg 2007; 19: 96-100.10.1016/S0915-6992(07)80023-9 ↗
25. 25) Ogawa T, Nishimura I. Genes differentially expressed in titanium implant healing. J Dent Res 2006; 85: 566-570.10.1177/154405910608500617 ↗
26. 26) Anada T, Kumagai T, Honda Y, Masuda T, Kamijo R, Kamakura S, et al. Dose-dependent osteogenic effect of octacalcium phosphate on mouse bone marrow stromal cells. Tissue Eng Part A 2008; 14: 965-978.10.1089/ten.tea.2007.0339 ↗
27. 27) Sato T, Anada T, Hamai R, Shiwaku Y, Tsuchiya K, Sakai S, et al. Culture of hybrid spheroids composed of calcium phosphate materials and mesenchymal stem cells on an oxygen-permeable culture device to predict in vivo bone forming capability. Acta Biomater 2019; 88: 477-490.10.1016/j.actbio.2019.03.001 ↗
28. 28) Takami M, Mochizuki A, Yamada A, Tachi K, Zhao B, Miyamoto Y, et al. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of nf-kappab ligand expression in osteoblasts. Tissue Eng Part A 2009; 15: 3991-4000.10.1089/ten.tea.2009.0065 ↗
29. 29) Hirayama B, Anada T, Shiwaku Y, Miyatake N, Tsuchiya K, Nakamura M, et al. Immune cell response and subsequent bone formation induced by implantation of octacalcium phosphate in a rat tibia defect. RSC Adv 2016; 6: S7475-7484.10.1039/C6RA10834B ↗
30. 30) Sai Y, Shiwaku Y, Anada T, Tsuchiya K, Takahashi T, Suzuki O. Capacity of octacalcium phosphate to promote osteoblastic differentiation toward osteocytes in vitro. Acta Biomater 2018; 69: 362-371.10.1016/j.actbio.2018.01.026 ↗
31. 31) Saito S, Hamai R, Shiwaku Y, Hasegawa T, Sakai S, Tsuchiya K, et al. Involvement of distant octacalcium phosphate scaffolds in enhancing early differentiation of osteocytes during bone regeneration. Acta Biomater 2021; 129: 309-322.10.1016/j.actbio.2021.05.017 ↗
32. 32) Kurobane T, Shiwaku Y, Anada T, Hamai R, Tsuchiya K, Baba K, et al. Angiogenesis involvement by octacalcium phosphate-gelatin composite-driven bone regeneration in rat calvaria critical-sized defect. Acta Biomater 2019; 88: 514-526.10.1016/j.actbio.2019.02.021 ↗
33. 33) Kikawa T, Kashimoto O, Imaizumi H, Kokubun S, Suzuki O. Intramembranous bone tissue response to biodegradable octacalcium phosphate implant. Acta Biomater 2009; 5: 1756-1766.10.1016/j.actbio.2008.12.008 ↗
34. 34) Kaji H. Effects of myokines on bone. Bonekey Rep 2016; 5: 826.10.1038/bonekey.2016.48 ↗
35. 35) Schindeler A, Liu R, Little DG. The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. Differentiation 2009; 77: 12-18.10.1016/j.diff.2008.09.007 ↗
36. 36) Liu R, Schindeler A, Little DG. The potential role of muscle in bone repair. J Musculoskelet Neuronal Interact 2010; 10: 71-76.
37. 37) Hamrick MW. A role for myokines in muscle-bone interactions. Exerc Sport Sci Rev 2011; 39: 43-47.10.1097/JES.0b013e318201f601 ↗
38. 38) Kawao N, Kaji H. Interactions between muscle tissues and bone metabolism. J Cell Biochem 2015; 116: 687-695.10.1002/jcb.25040 ↗
39. 39) Suzuki O, Shiwaku Y, Hamai R. Octacalcium phosphate bone substitute materials: Comparison between properties of biomaterials and other calcium phosphate materials. Dent Mater J 2020; 39: 187-199.10.4012/dmj.2020-001 ↗
40. 40) Bae SC, Lee KS, Zhang YW, Ito Y. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF. J Bone Joint Surg Am 2001; 83-A Suppl 1: S48-55.10.2106/00004623-200100001-00007 ↗
41. 41) Sakai S, Anada T, Tsuchiya K, Yamazaki H, Margolis HC, Suzuki O. Comparative study on the resorbability and dissolution behavior of octacalcium phosphate, β-tricalcium phosphate, and hydroxyapatite under physiological conditions. Dent Mater J 2016; 35: 216-224.10.4012/dmj.2015-255 ↗
42. 42) Tanaka K, Matsumoto E, Higashimaki Y, Katagiri T, Sugimoto T, Seino S, et al. Role of osteoglycin in the linkage between muscle and bone. J Biol Chem 2012; 287: 11616-11628.10.1074/jbc.M111.292193 ↗
43. 43) Suzuki O. Octacalcium phosphate: Osteoconductivity and crystal chemistry. Acta Biomater 2010; 6: 3379-3387.10.1016/j.actbio.2010.04.002 ↗
44. 44) Ohnishi Y, Kawakita Y, Yamasaki K, Fujisato T, Uto S. Evaluation of a cellular differentiation and a contraction of c2c 12 by cellular membrane potential. J Soc Elect Mat Eng 2008; 17: 38-43.
45. 45) Moreno EC, Margolis HC. Composition of human plaque fluid. J Dent Res 1988; 67: 1181-1189.10.1177/00220345880670090701 ↗
46. 46) Aoba T, Moreno EC. The enamel fluid in the early secretory stage of porcine amelogenesis: Chemical composition and saturation with respect to enamel mineral. Calcif Tissue Int 1987; 41: 86-94.10.1007/BF02555250 ↗
47. 47) Moreno EC, Kresak M, Zahradnik RT. Fluoridated hydroxyapatite solubility and caries formation. Nature 1974; 247: 64-65.10.1038/247064a0 ↗
48. 48) Tung MS, Eidelman N, Sieck B, Brown WE. Octacalcium phosphate solubility product from 4 to 37ºC. J Res Natl Bur Stand 1997; 613: 613-624.10.6028/jres.093.153 ↗
49. 49) Moreno EC, Brown WE, Osborn G. Solubility of dicalcium phosphate dihydrate in aqueous systems. Soil Sci Soc Am J 1960; 24: 94-98.10.2136/sssaj1960.03615995002400020009x ↗
50. 50) Hamai R, Tsuchiya K, Suzuki O. Enhancement of the cytokine adsorption capacity of octacalcium phosphate by interaction-controlled glycosaminoglycan modification to promote osteoblastic differentiation. Langmuir 2024; 40: 27253-27269.10.1021/acs.langmuir.4c03067 ↗
51. 51) McKinsey TA, Zhang CL, Olson EN. Signaling chromatin to make muscle. Curr Opin Cell Biol 2002; 14: 763-772.10.1016/S0955-0674(02)00389-7 ↗
52. 52) Sun JS, Tsuang YH, Yao CH, Liu HC, Lin FH, Hang YS. Effects of calcium phosphate bioceramics on skeletal muscle cells. J Biomed Mater Res 1997; 34: 227-233.10.1002/(SICI)1097-4636(199702)34:2<227::AID-JBM12>3.0.CO;2-F ↗
53. 53) Sinha S, Elbaz-Alon Y, Avinoam O. Ca2+ as a coordinator of skeletal muscle differentiation, fusion and contraction. FEBS J 2022; 289: 6531-6542.10.1111/febs.16552 ↗
54. 54) Cho CH, Woo JS, Perez CF, Lee EH. A focus on extracellular Ca2+ entry into skeletal muscle. Exp Mol Med 2017; 49: e378.10.1038/emm.2017.208 ↗
55. 55) Porter GA Jr, Makuck RF, Rivkees SA. Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem 2002; 277: 28942-28947.10.1074/jbc.M203961200 ↗
56. 56) Raimann A, Dangl A, Javanmardi AH, Ertl AP, Egerbacher M, Greber-Platzer S, et al. Effects of inorganic phosphate and FGF23 on C2C12 myoblast cells. Bone Abstracts 2015; 4: P109.10.1530/boneabs.4.P109 ↗
57. 57) Wang M, Chen F, Wang J, Chen X, Liang J, Yang X, et al. Calcium phosphate altered the cytokine secretion of macrophages and influenced the homing of mesenchymal stem cells. J Mater Chem B 2018; 6: 4765-4774.10.1039/C8TB01201F ↗
58. 58) Hamrick MW. The skeletal muscle secretome: An emerging player in muscle-bone crosstalk. Bonekey Rep 2012; 1: 60.10.1038/bonekey.2012.60 ↗
59. 59) Fei Y, Xiao L, Doetschman T, Coffin DJ, Hurley MM. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the wnt signaling pathway. J Biol Chem 2011; 286: 40575-40583.10.1074/jbc.M111.274910 ↗
60. 60) Colaianni G, Cuscito C, Mongelli T, Oranger A, Mori G, Brunetti G, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol 2014; 2014: 902186.10.1155/2014/902186 ↗
61. 61) Qiao X, Nie Y, Ma Y, Chen Y, Cheng R, Yin W, et al. Irisin promotes osteoblast proliferation and differentiation via activating the map kinase signaling pathways. Sci Rep 2016; 6: 18732.10.1038/srep18732 ↗
62. 62) Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A 2015; 112: 12157-12162.10.1073/pnas.1516622112 ↗
63. 63) Wang FS, Wu RW, Chen YS, Ko JY, Jahr H, Lian WS. Biophysical modulation of the mitochondrial metabolism and redox in bone homeostasis and osteoporosis: How biophysics converts into bioenergetics. Antioxidants 2021; 10: 1394.10.3390/antiox10091394 ↗
64. 64) Ohyama Y, Ohta Y, Sugama R, Minoda Y, Masuda S, Terai H, et al. Effect of recombinant irisin on recombinant human bone morphogenetic protein-2 induced osteogenesis and osteoblast differentiation. Biochem Biophys Res Commun 2024; 734: 150787.10.1016/j.bbrc.2024.150787 ↗
65. 65) Anada T, Araseki A, Matsukawa S, Yamasaki T, Kamakura S, Suzuki O. Effect of octacalcium phosphate ionic dissolution products on osteoblastic cell differentiation. Key Eng Mater 2008; 361: 31-34.10.4028/www.scientific.net/KEM.361-363.31 ↗
66. 66) Xie J, Baumann MJ, McCabe LR. Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J Biomed Mater Res A 2004; 71: 108-117.10.1002/jbm.a.30140 ↗
67. 67) Xie J, Baumann MJ, McCabe LR. Adsorption of serum fetuin to hydroxylapatite does not contribute to osteoblast phenotype modifications. J Biomed Mater Res A 2005; 73: 39-47.10.1002/jbm.a.30246 ↗
68. 68) Raina DB, Gupta A, Petersen MM, Hettwer W, McNally M, Tägil M, et al. Muscle as an osteoinductive niche for local bone formation with the use of a biphasic calcium sulphate/hydroxyapatite biomaterial. Bone Joint Res 2016; 5: 500-511.10.1302/2046-3758.510.BJR-2016-0133.R1 ↗
69. 69) Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-17.10.1161/01.RES.87.7.e10 ↗